Disarming flu viruses.
Laver
W G
WG
Australian National University, Canberra.
Bischofberger
N
N
Webster
R G
RG
D000588:Amines / Q000627:therapeutic use*; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D004196:Disease Outbreaks; D015195:Drug Design; D004791:Enzyme Inhibitors; D006146:Guanidines; D006388:Hemagglutinins; D006801:Humans; D007252:Influenza Vaccines; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D009975:Orthomyxoviridae / Q000187:drug effects / Q000201:enzymology / Q000502:physiology; D053139:Oseltamivir; D011714:Pyrans; D012794:Sialic Acids / Q000627:therapeutic use*; D014777:Virus Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D014779:Virus Replication / Q000187:drug effects; D053243:Zanamivir
D000588:Amines; D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D006146:Guanidines; D006388:Hemagglutinins; D007252:Influenza Vaccines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir